Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-07 @ 5:39 AM
Study NCT ID:
NCT00519259
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
2006-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
Sponsor:
National Institute on Drug Abuse (NIDA)
Organization:
Study Overview
Official Title:
Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline
Status:
UNKNOWN
Status Verified Date:
2006-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: